Niraxx is a NeuroTech company that aims to empower individuals to take charge of brain health for life by delivering personalized, e-textile solutions integrating photobiomodulation (PBM) in clothing. Niraxx R&D team has recently announced positive initial results from its Proof of Concept model Brain Pacer Efficacy Study. Early findings show that neuronal connectivity is significantly increased. Enhanced neuronal connectivity means faster transmission of information from neuron to neuron, resulting in better attention and cognition. Global neuromodulation market size is expected to reach $11.7 billion by 2022, registering a CAGR of 13.1% from 2016 to 2022. Medical wearables has saved public healthcare cost $3 trillion a year. With niraxx e-textile solutions, our proposition is exciting that there will be collaboration and integration between two industries: healthcare and garment.